Tammie L. S. Benzinger, MD, PhD
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Tammie L. S. Benzinger, MD, PhD sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Tammie L. S. Benzinger, MD, PhD: 8 sponsored US clinical trials, 3 recruiting.
Tammie L. S. Benzinger, MD, PhD sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Alzheimer Disease, with 5 trials.
Upper-quartile sponsor footprint
Tammie L. S. Benzinger, MD, PhD sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
NCT04579120
Imaging Biomarkers in Preclinical and Symptomatic AD
NCT04134923
F 18 T807 Tau PET Imaging of Alzheimer's Disease
NCT02414347
Investigation of Inflammation Using [C-11]-CS1P1
NCT04517552
F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected
NCT03279523
Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans
NCT03287765
F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)
NCT02414282
F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
NCT02414230
Therapeutic Areas
What is open in the Tammie L. S. Benzinger, MD, PhD pipeline
3 recruiting of 8 indexed (38% open); 4 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Alzheimer Disease (5 trials), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Tammie L. S. Benzinger, MD, PhD: open-pipeline peers nationwide
Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Tammie L. S. Benzinger, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 38% open enrollment (± trial volume)
- American Thrombosis and Hemostasis Network · 38% recruiting · 8 trials
- AskBio · 38% recruiting · 8 trials
- Athletic Greens International · 38% recruiting · 8 trials
- Banner Health · 38% recruiting · 8 trials
Related
What to do with this Tammie L. S. Benzinger, MD, PhD page
8 registered trials is a research-attention snapshot, not an endorsement of Tammie L. S. Benzinger, MD, PhD or any single study.
- 3 of Tammie L. S. Benzinger, MD, PhD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Tammie L. S. Benzinger, MD, PhD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Tammie L. S. Benzinger, MD, PhD pipeline card: 8 registered trials from official public datasets.Report a data error.